Skip to main content
. 2020 Dec 7;23(3):476–485. doi: 10.1002/ejhf.2060

Figure 2.

EJHF-2060-FIG-0002-c

Impact of potential unmeasured confounders on the association between use of renin–angiotensin system inhibitors and risk of (A) incident hospitalization/death for COVID‐19 and (B) all‐cause death in COVID‐19 cases. ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; CI, confidence interval; HR, hazard ratio; OR, odds ratio.